Patient monitoring devices are used to observe vital parameters, such as heart rate and blood pressure of the patients. These devices, such as pulse oximeters, capnographs, and cardiac monitors, are increasingly used in hospitals, clinics, and various outpatient centers during minor & major surgeries and are expected to monitor the vital signs of multiple patients at the same time. The global patient monitoring devices market was valued at $21,127.3 million in 2017, and is estimated to reach at $32,435.8 million by 2025, registering a CAGR of 6.2% from 2018 to 2025.
The report analyzes the patient monitoring devices market based on three segments, namely, product type, end user, and region. On the basis of product type, it is divided into nine segments—hemodynamic, neuromonitoring, cardiac, fetal & neonatal, respiratory, multiparameter, remote patient, weight, and temperature monitoring devices. Hemodynamic monitoring devices can be further segmented into blood glucose, cholesterol, blood gas & electrolyte analyzer, and blood pressure monitors. Neuromonitoring devices is further categorized into electroencephalograph devices, magnetoencephalography devices, intracranial pressure monitors, transcranial dopplers, and cerebral oximeters. Cardiac monitoring devices are further divided into electrocardiogram devices, Holter monitors, event monitors, and others (implantable loop recorders, cardiac output monitoring devices, and others). Fetal & neonatal monitoring devices are further categorized into ultrasound fetal doppler, internal fetal monitor, and intrauterine pressure catheters. Respiratory monitoring devices are further segmented into capnograph, spirometer, sleep apnea monitor, and pulse oximeter. Multiparameter monitoring devices are further categorized into high, mid, and low acuity. Based on end user, the market is categorized into three segments—hospitals & clinics, home settings, and ambulatory surgical centers. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The global patient monitoring devices market is driven by increase in the geriatric population, growth in the prevalence of patients suffering from different lifestyle diseases, and rise in the adoption rate of remote patient monitoring devices. However, the cost associated with this technology and issues related to government regulations & reimbursements are expected to hamper the global market growth. With the advancements in wireless technology, these devices are used to remotely monitor the physiological parameters of the patients, such as blood glucose level, blood pressure, heart rate, and provide appropriate treatment to the patients. The growth in competition has led to collaborations and product launches by key players in the patient monitoring devices market. Moreover, Nihon Kohden announced the launch of the advanced bedside monitor called BSM-3500. These monitors are designed to meet the needs of ambulatory surgery and specialty centers. BSM-3500 monitors help provide a range of standard monitoring facilities and many critical capabilities in low acuity settings.
KEY MARKET BENEFITS
The global patient monitoring devices market report provides an extensive analysis of the current market trends and future estimations in the market.
The market scenario is comprehensively analyzed with respect to the product and end users.
The market estimations are based on high-end analysis of the key developments.
Recent developments and key manufacturers are listed to understand the competitive market scenario.
In-depth analysis based on region provides an understanding of the regional market, which assists in strategic business planning.
KEY PLAYERS PROFILED
Medtronic, Inc.
Biotronik
F. Hoffmann-La Roche Ltd.
GE Healthcare Ltd.
Masimo Corporation
Nihon Kohden Corporation
Johnson and Johnson
Omron Healthcare Co. Ltd.
Abbott Laboratories
Koninklijke Philips N.V.
KEY MARKET SEGMENTS
By Product Type
Hemodynamic Monitoring Devices
o Blood Glucose o Cholesterol o Blood Gas & Electrolyte Analyzers/Monitors o Blood Pressure
Neuromonitoring Devices
o Electroencephalograph (EEG) Devices o Magnetoencephalograph (MEG) Devices o Intracranial Pressure Monitors (ICP) o Transcranial Dopplers (TCD) o Cerebral Oximeters
Cardiac Monitoring Devices
o Electrocardiogram (ECG) Devices o Implantable Loop Recorders (ILR) o Cardiac Output Monitoring (COM) Devices o Event Monitors
Fetal & Neonatal Monitoring Devices
o Ultrasound Fetal Dopplers o Internal Fetal Monitors
Respiratory Monitoring Devices
o Capnographs o Anesthesia Monitors o Spirometers o Pulse Oximeters o Sleep Apnea Monitoring Devices
Multiparameter Monitoring Devices
o High Acuity o Mid Acuity o Low Acuity
Remote Patient Monitoring Devices
Weight Monitoring Devices
Temperature Monitoring Devices
By End User
Hospitals & Clinics
Home Settings
Ambulatory Surgical Centers (ASC)
By Region
North America
o U.S. o Canada o Mexico
Europe
o Germany o UK o France o Spain o Italy o Russia o Rest of Europe
Asia-Pacific
o Japan o China o Australia o India o South Korea o Taiwan o Rest of Asia-Pacific
LAMEA
o Brazil o Turkey o Venezuela o Republic of South Africa o Saudi Arabia o Rest of LAMEA
The other players of the catheters market include (companies not profiled in the report):
Honeywell International Inc.
Siemens Healthcare
Lifewatch AG
Care Innovations, LLC.
St. Jude Medical, Inc.
Smiths Medical
Note: Product cover images may vary from those shown
Chapter 1: INTRODUCTION 1.1. Report description 1.2. Key benefits 1.3. Key market segments 1.4. Research methodology 1.4.1. Secondary research 1.4.2. Primary research 1.4.3. Analyst tools and models
Chapter 2: EXECUTIVE SUMMARY 2.1. CXO perspective
Chapter 3: MARKET OVERVIEW 3.1. Market definition and scope 3.2. Key findings 3.2.1. Top investment pockets 3.2.2. Top winning strategies 3.3. Government regulations 3.3.1. U.S. FDA 3.3.2. Europe CE mark 3.3.3. Ministry of Health, Labor, and Welfare (MHLW) 3.4. Reimbursement scenarios 3.5. Clinical trials 3.6. Patent analysis 3.6.1. U.S. patent analysis, by market participant 3.6.2. Europe patent analysis, by market participant 3.6.3. China patent analysis, by market participant 3.6.4. Canada patent analysis, by market participant 3.6.5. Japan patent analysis by market participant 3.6.6. Other countries patent analysis, by market participant 3.7. Top impacting factors 3.8. Market Dynamics 3.8.1. Drivers 3.8.1.1. Rise in the prevalence of lifestyle diseases 3.8.1.2. Increase in the geriatric population 3.8.1.3. Rise in the adoption rate of remote patient monitoring devices 3.8.2. Restrains 3.8.2.1. Government regulations and reimbursement issues 3.8.2.2. Limited awareness and high costs 3.8.3. Opportunities 3.8.3.1. Untapped markets in developing countries 3.8.3.2. Technological advancements
Chapter 4: PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE 4.1. Overview 4.1.1. Market size and forecast 4.2. Hemodynamic monitoring devices 4.2.1. Key market trends 4.2.2. Key growth factors and opportunities 4.2.3. Market size and forecast 4.2.4. Blood glucose monitors 4.2.4.1. Market size and forecast 4.2.5. Blood gas and electrolyte analyzers/monitors 4.2.5.1. Market size and forecast 4.2.6. Blood pressure monitors 4.2.6.1. Market size and forecast 4.3. Neuromonitoring devices 4.3.1. Key market trends 4.3.2. Key growth factors and opportunities 4.3.3. Market size and forecast 4.3.4. Electroencephalograph (EEG) devices 4.3.4.1. Market size and forecast 4.3.5. Transcranial dopplers (TCD) 4.3.5.1. Market size and forecast 4.3.6. Magnetoencephalograph (MEG) devices 4.3.6.1. Market size and forecast 4.3.7. Intracranial pressure monitors (ICP) 4.3.7.1. Market size and forecast 4.3.8. Cerebral oximeters 4.3.8.1. Market size and forecast 4.4. Cardiac monitoring devices 4.4.1. Key market trends 4.4.2. Key growth factors and opportunities 4.4.3. Market size and forecast 4.4.4. Electrocardiogram (ECG) devices 4.4.4.1. By type 4.4.4.2. By lead type 4.4.4.3. Market size and forecast 4.4.5. Holter monitors 4.4.5.1. Market size and forecast 4.4.6. Event monitors 4.4.6.1. By type 4.4.6.2. By technology 4.4.6.3. Market size and forecast 4.4.7. Others (Implantable loop recorder, Cardiac output monitor and others) 4.4.7.1. Market size and forecast 4.5. Fetal and neonatal monitoring devices 4.5.1. Key market trends 4.5.2. Key growth factors and opportunities 4.5.3. Market size and forecast 4.5.4. Ultrasound 4.5.4.1. Market size and forecast 4.5.5. Electronic Fetal Monitoring Devices 4.5.5.1. Market size and forecast 4.5.6. Fetal Doppler Monitoring Devices 4.5.6.1. Market size and forecast 4.5.7. Other Fetal and Neonatal Monitoring Devices 4.5.7.1. Market size and forecast 4.6. Respiratory monitors 4.6.1. Key market trends 4.6.2. Key growth factors and opportunities 4.6.3. Market size and forecast 4.6.4. Capnographs 4.6.4.1. Market size and forecast 4.6.5. Pulse oximeters 4.6.5.1. Market size and forecast 4.6.6. Sleep apnea monitors 4.6.6.1. Market size and forecast 4.6.7. Spirometers 4.6.7.1. Market size and forecast 4.7. Multiparameter monitoring devices 4.7.1. Key market trends 4.7.2. Key growth factors and opportunities 4.7.3. Market size and forecast 4.7.4. High acuity 4.7.4.1. Market size and forecast 4.7.5. Mid acuity 4.7.5.1. Market size and forecast 4.7.6. Low acuity 4.7.6.1. Market size and forecast 4.8. Remote patient monitoring devices 4.8.1. Key market trends 4.8.2. Key growth factors and opportunities 4.8.3. Market size and forecast 4.9. Weight monitoring devices 4.9.1. Key market trends 4.9.2. Key growth factors and opportunities 4.9.3. Market size and forecast 4.10. Temperature monitoring devices 4.10.1. Key market trends 4.10.2. Key growth factors and opportunities 4.10.3. Market size and forecast 4.11. Urine output monitoring 4.11.1. Key market trends 4.11.2. Key growth factors and opportunities 4.11.3. Market size and forecast
Chapter 5: PATIENT MONITORING DEVICES MARKET, BY END USER 5.1. Overview 5.1.1. Market size and forecast 5.2. Hospitals 5.2.1. Market size and forecast 5.3. Home settings 5.3.1. Market size and forecast 5.4. Ambulatory surgical centers (ASC) 5.4.1. Market size and forecast
Chapter 6: PATIENT MONITORING DEVICES MARKET, BY GEOGRAPHY 6.1. Overview 6.1.1. Market size and forecast 6.2. North America 6.2.1. Market size and forecast 6.2.1.1. U.S. market size and forecast 6.2.1.2. Canada market size and forecast 6.2.1.3. Mexico market size and forecast 6.3. Europe 6.3.1. Market size and forecast 6.3.1.1. Germany market size and forecast 6.3.1.2. France market size and forecast 6.3.1.3. UK market size and forecast 6.3.1.4. Italy market size and forecast 6.3.1.5. Spain market size and forecast 6.3.1.6. Rest of Europe market size and forecast 6.4. Asia-Pacific 6.4.1. Market size and forecast 6.4.1.1. Japan market size and forecast 6.4.1.2. China market size and forecast 6.4.1.3. Australia market size and forecast 6.4.1.4. India market size and forecast 6.4.1.5. South Korea market size and forecast 6.4.1.6. Rest of Asia-Pacific market size and forecast 6.5. LAMEA 6.5.1. Market size and forecast 6.5.1.1. Brazil market size and forecast 6.5.1.2. Turkey market size and forecast 6.5.1.3. Venezuela market size and forecast 6.5.1.4. Saudi Arabia market size and forecast 6.5.1.5. Rest of LAMEA market size and forecast
Chapter 7: COMPANY PROFILES 7.1. Abbott Laboratories 7.1.1. Company overview 7.1.2. Company snapshot 7.1.3. Operating business segments 7.1.4. Product portfolio 7.1.5. Business performance 7.1.6. Key strategic moves and developments 7.2. Biotronik SE & Co. KG 7.2.1. Company overview 7.2.2. Company snapshot 7.2.3. Operating business segments 7.2.4. Product portfolio 7.2.5. Key strategic moves and developments 7.3. General Electric Company (GE Healthcare) 7.3.1. Company overview 7.3.2. Company snapshot 7.3.3. Operating business segments 7.3.4. Product portfolio 7.3.5. Business performance 7.3.6. Key strategic moves and developments 7.4. F. Hoffmann-La Roche Ltd. 7.4.1. Company overview 7.4.2. Company snapshot 7.4.3. Operating business segments 7.4.4. Product portfolio 7.4.5. Business performance 7.4.6. Key strategic moves and developments 7.5. Johnson & Johnson 7.5.1. Company overview 7.5.2. Company snapshot 7.5.3. Operating business segments 7.5.4. Product portfolio 7.5.5. Business performance 7.5.6. Key strategic moves and developments 7.6. Koninklijke Philips N.V. (Philips Healthcare) 7.6.1. Company overview 7.6.2. Company snapshot 7.6.3. Operating business segments 7.6.4. Product portfolio 7.6.5. Business performance 7.6.6. Key strategic moves and developments 7.7. Masimo Corporation 7.7.1. Company overview 7.7.2. Company snapshot 7.7.3. Product portfolio 7.7.4. Business performance 7.7.5. Key Strategic Moves: 7.8. Medtronic Plc. (Covidien Ltd.) 7.8.1. Company overview 7.8.2. Company snapshot 7.8.3. Operating business segments 7.8.4. Product portfolio 7.8.5. Business performance 7.8.6. Key strategic moves and developments 7.9. Nihon Kohden Corporation 7.9.1. Company overview 7.9.2. Company snapshot 7.9.3. Operating business segments 7.9.4. Product portfolio 7.9.5. Business performance 7.9.6. Key strategic moves and developments 7.10. Omron Corporation 7.10.1. Company overview 7.10.2. Company snapshot 7.10.3. Operating business segments 7.10.4. Product portfolio 7.10.5. Business performance 7.10.6. Key Strategic Moves:
Note: Product cover images may vary from those shown
According to this report titled, 'Patient Monitoring Devices Market by Product and End User: Global Opportunity Analysis and Industry Forecast, 2017 - 2023,' the patient monitoring devices market size accounted for $22,641 million in 2017, and is estimated to reach $37,187 million by 2025, registering a CAGR of 6.4% from 2018 to 2025. The cardiac monitoring devices segment accounted for one-third of the global patient monitoring devices market share in 2017, and is expected to maintain its dominance throughout the analysis period.
Patient monitoring devices are utilized to observe and evaluate the vital physiological parameters of critically ill patients. These are used in emergency, operating rooms, and intensive care units. Different physiological parameters, such as heart rate, oxygen level, and blood glucose level, are assessed with the help of these devices. Patient monitoring devices are used in an inpatient and outpatient setting, such as emergency medical services and transport, owing to the advancements in patient monitoring technology.
The major factors that boost the market include ease of use, portability of device, increase in the aging population, and growth in the prevalence of patients suffering from various lifestyle diseases, such as obesity, chronic liver diseases, and stroke. In addition, the introduction of breakthrough patient monitoring devices is expected to supplement the market growth. However, the cost associated with this technology and issues related to government regulations & reimbursements are expected to hamper the global market growth. Furthermore, the technological advancements in these devices and the presence of untapped market in the developing region are expected to open new avenues for the growth of the patient monitoring devices market.
Based on product type, the patient monitoring devices market is categorized into hemodynamic, neuromonitoring, cardiac, fetal & neonatal, urine output monitoring, respiratory, multiparameter, remote patient, weight, and temperature monitoring devices. Cardiac monitoring devices are further divided into electrocardiogram devices, Holter monitors, event monitors, and others (implantable loop recorders, cardiac output monitoring devices, and others). The cardiac monitoring devices segment dominated the global market in 2017, and is expected to continue its dominance throughout the forecast period. These are attributed to the various applications of the cardiac monitoring devices for cardiovascular surgeries and its ability to monitor the severity of range of cardiovascular diseases. However, this segment is estimated to grow at the highest rate, owing to the growth in popularity of the advantages in this segment.
Patient monitoring devices are most commonly and widely used in hospitals & clinics for various procedures. Thus, it is the dominant end user segment of the patient monitoring devices market and is expected to maintain its market position throughout the forecast period. As there is a rise in popularity of self-monitoring devices, home setting segment is anticipated to be the fastest growing segment.
In 2017, North America and Europe possess the highest growth potential due to established reimbursement policies, high buying power, rapid adoption of remote patient monitoring devices, rise in the geriatric population, and increase in prevalence of patients with lifestyle diseases. However, the patient monitoring devices market is expected to gain traction in the developing regions of Asia-Pacific and Latin America, due to the increase in urbanization & disposable income, growth in awareness about patient monitoring devices, and large number of undiagnosed patients.
Key Findings of the Patient Monitoring Devices Market:
The intracranial pressure monitor segment is estimated to exhibit a CAGR of 8.3%. U.S. was the largest economy market in 2017, and is anticipated to maintain its dominance until 2025. The remote patient monitoring devices segment is anticipated to be the fastest growing segment throughout the analysis period. Electronic fetal monitoring devices market is projected to grow at a CAGR of 7.6%. China is the fastest growing segment in the Asia-Pacific region, registering a CAGR of 9.6%
The key companies profiled in the report of patient monitoring devices market include Medtronic, Inc., Biotronik, F. Hoffmann-La Roche Ltd., GE Healthcare Ltd., Masimo Corporation, Nihon Kohden Corporation, Johnson & Johnson, Omron Healthcare Co. Ltd., Abbott Laboratories, and Koninklijke Philips N.V.
The other players in the value chain of the patient monitoring devices industry include Honeywell International Inc., Siemens Healthcare, Lifewatch AG, Care Innovations, LLC., Smiths Medical, and St. Jude Medical, Inc.
Note: Product cover images may vary from those shown
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic news articles and other related releases for market evaluation
Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
